Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Alpha-hydroxy acids, like glycolic acid, safely improve skin issues and work on all skin types.

Stem cells from hair follicles can safely treat hair loss.

An imbalanced gut and lack of biotin can cause hair loss in mice.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

White lupin uses specific genes to grow root hairs and access phosphorus when it's scarce.

A weight loss program with a special fast helped patients lose an average of 41-47 pounds and improved their health, but maintaining the weight loss was challenging.

Hidradenitis suppurativa is caused by genetic factors, inflammation, bacteria, hormones, and lifestyle factors like obesity and smoking.

Acne treatment varies, with topical and systemic therapies effective, and more research needed on treatment order and long-term effects.

Stem cells are crucial for tissue growth, cancer treatment, and disease modeling, but challenges remain in clinical use.

The dermal regeneration template is effective in skin regeneration, reducing scarring, and has potential for future improvements.

The conclusion is that recognizing hair growth cycles can improve the precision of dietary and health assessments from hair analysis.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Platelet preparations generally show positive effects on wound healing and facial rejuvenation, but more thorough research is needed to confirm their effectiveness.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Platelet-Rich Plasma (PRP) increases the number of new hair follicles and speeds up hair formation.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Applying a specific inhibitor lightens skin and hair color.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Bombax ceiba stem bark extracts can lower blood pressure, but high doses can be toxic and lethal.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.